Single-dose trastuzumab monotherapy achieved pathological complete response (pCR) in a patient with HER2-positive breast cancer: a case report

Single-dose trastuzumab monotherapy achieved pathological complete response (pCR) in a patient with HER2-positive breast cancer: a case report

Abstract Background With advances in breast cancer treatment, the importance of de-escalation therapy to reduce harm during the treatment of elderly patients has attracted attention in recent years. Certain patient populations are expected to have a superior response to anti-HER2 drugs, particularly...

Full description

Bibliographic Details
Main Authors: Ayaka Isogai, Haruru Kotani, Masataka Sawaki, Masaya Hattori, Akiyo Yoshimura, Ayumi Kataoka, Kazuki Nozawa, Yuri Ozaki, Yuka Endo, Akira Nakakami, Rie Komaki, Hiroji Iwata
Format: Article
Language:English
Published: SpringerOpen 2023-06-01
Series:Surgical Case Reports
Subjects:
Breast cancer
HER2-positive
Trastuzumab
Monotherapy
Single dose
Online Access:https://doi.org/10.1186/s40792-023-01661-4

Internet

https://doi.org/10.1186/s40792-023-01661-4

Similar Items